
    
      This is a phase 3, randomized, double masked, two arms study conducted in Malawi, Southeast
      Africa. The study is conducted among nonpregnant HIV infected or uninfected women of
      reproductive age. Intermittent mass treatment approaches are followed where women are
      randomized to antibiotic intravaginal treatment or placebo at enrollment. Women receive
      assigned product every three months for one year.
    
  